Scientists have developed a potential new therapeutic approach for synovial sarcoma, one of the most common soft-tissue cancers in teenagers and young adults. At present the long-term survival rates for synovial sarcoma patients is well below 50 percent; a fact that…
Study Links Widely-used Drug Azathioprine to Skin Cancers
A drug used to treat inflammatory bowel disease, arthritis, and vasculitis as well as to prevent organ rejection in transplant patients has been identified as an essential contributor to Skin Cancer development, in a research study carried out at the University…
New Method Reveals How Well Cancer Drugs Hit Their Targets
Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumor in real time, revealing which cells interact with the drug and which cells…
ASCO: AstraZeneca pioneer Lynparza scores with Zytiga combo in prostate cancer
CHICAGO—At last year’s American Society of Clinical Oncology annual meeting, AstraZeneca posted Lynparza data that would eventually make it the first in its class to break into breast cancer. This time around, it’s trying to grab the same crown in prostate cancer….
Nanoparticles Take on Brain Cancer
Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma, and the median life expectancy for patients diagnosed with the disease is less than 15 months. MIT…
CAR-T Immunotherapy Eliminates Metastatic Colorectal Cancer in Mice
Immunotherapy has given patients and oncologists new options, which for some patients, has meant cures for diseases that had been untreatable. Colorectal cancer has a high mortality rate in advanced stages of the disease with few effective therapies. Researchers at the…
Merck’s Keytruda shows up its rivals with NICE backing in bladder cancer
Merck just accomplished a feat its rivals haven’t so far. Friday, England’s National Institute for Health and Care Excellence, the company’s Keytruda to treat certain bladder cancer patients, making it the first immuno-oncology med to win the cost watchdog’s favor for that use….
Alcohol-abuse Drug Antabuse Kills Cancer Cells
A new study of Alcohol-abuse Drug Antabuse is effective against cancer cells. The study has researched by an international team including researchers from Karolinska Institutet. The study also identifies a potential mechanism of action for the anti-tumor effect. As developing new cancer…
Parasite Treatment Fights Prostate Cancer
Cancer researchers at the University of Bergen (UiB) in Norway have been experimenting with hundreds of known drugs in recent years to see how they influence cancer cells of Prostate Cancer. Their most recent discovery shows that a medication prescribed for…
Cancer Drug Effective for Heart Failure Treatment, Preclinical Study Shows
Preclinical Cancer Drug Discoveries Researchers from the Gladstone Institutes have discovered that newly-developed cancer drugs may also provide a treatment option for heart failure patients. Heart failure is the leading cause of mortality, hospitalization and healthcare costs in the U.S. Even…